Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada

This publication has 25 references indexed in Scilit:

• Spread ofStreptococcus pneumoniaeand Antibiotic‐ResistantS. pneumoniaefrom Day‐Care Center Attendees to Their Younger Siblings
  The Journal of Infectious Diseases, 2002
• Reduction of Nasopharyngeal Carriage ofStreptococcus pneumoniaeafter Administration of a 9‐Valent Pneumococcal Conjugate Vaccine to Toddlers Attending Day Care Centers
  The Journal of Infectious Diseases, 2002
• Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
  New England Journal of Medicine, 2001
• Surveillance of Invasive Streptococcus pneumoniae Infection in the Province of Quebec, Canada, from 1996 to 1998: Serotype Distribution, Antimicrobial Susceptibility, and Clinical Characteristics
  Journal of Clinical Microbiology, 2001
• Invasive Pneumococcal Infections in Canadian Children, 1991-1998: Implications for New Vaccination Strategies
  Clinical Infectious Diseases, 2000
• Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
  The Pediatric Infectious Disease Journal, 2000
• A benefit-cost analysis of two-dose measles immunization in Canada
  Vaccine, 1998
• Reduction of Nasopharyngeal Carriage of Pneumococci during the Second Year of Life by a Heptavalent Conjugate Pneumococcal Vaccine
  The Journal of Infectious Diseases, 1996
• Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness
  Risk Analysis, 1995
• Pneumonia in pediatric outpatients: Cause and clinical manifestations
  The Journal of Pediatrics, 1987